Bio-Techne
TECH
#1989
Rank
$9.61 B
Marketcap
$61.68
Share price
-2.93%
Change (1 day)
-16.16%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of September 2025 : $0.39 Billion USD

According to Bio-Techne's latest financial reports the company's total debt is $0.39 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-06-30$0.41 B-7.79%
2023-06-30$0.45 B39.57%
2022-06-30$0.32 B-22.49%
2021-06-30$0.42 B-2.99%
2020-06-30$0.43 B-14.18%
2019-06-30$0.50 B49.01%
2018-06-30$0.33 B-1.39%
2017-06-30$0.34 B260.88%
2016-06-30$95.25 M23.67%
2015-06-30$77.02 M494.96%
2014-06-30$12.94 M
2006-06-30$13.42 M-8.13%
2005-06-30$14.61 M-7.83%
2004-06-30$15.85 M-7.19%
2003-06-30$17.08 M-5.34%
2002-06-30$18.05 M-4.67%
2001-06-30$18.93 M-4.17%
2000-06-30$19.75 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Thermo Fisher Scientific
TMO
$35.68 B 8,944.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
$1.39 B 253.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
$19.34 B 4,803.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
$16.85 B 4,173.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
$2.12 B 439.25%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
General Electric
GE
$20.83 B 5,182.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
$3 M-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA